SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ArQule, Inc. (ARQL)
An SI Board Since April 2003
Posts SubjectMarks Bans Symbol
545 40 0 ARQL
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
I was surprised to find that there is no thread for ArQule. Perhaps there was once, and it died. Not unlike the stock price. My curiosity got piqued when I found that BVF had recently acquired an 11% stake. Lately Pfizer has taken one of similar size pursuant to a milestone. Currently, ARQL trades for way less than cash, and I know nothing about it.

Any help appreciated.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
545some insider buys here, fwiw.mopgcw-11/17/2014
544Thanks for this. I'm still long ARQL myself. Just listened to today's mcbio-3/5/2014
543Good discussion on timing of any ARQL entry over on iHub. Look for Mcbio.tom pope-3/4/2014
542Couple of papers regarding the non-MET mechanism by which tivantinib also operattuck-3/4/2014
541ARQL MARQUEE NSCLC presentation at ESMO today: files.shareholder.com . Per slidmcbio-9/29/2013
540These are all very fair questions and caveats. We've had a good discussion mcbio-9/6/2013
539And now they've had to lower the dose by 50% due to neutropenia. Considerintuck-9/5/2013
538>>Daiichi Sankyo Company, Limited (TSE 4568) and ArQule, Inc. (ARQL) todatuck-1/31/2013
537>Shouldn't the burn rate decline with the completion of the trial -- or dpgo-neil-10/2/2012
536Shouldn't the burn rate decline with the completion of the trial -- or did ymopgcw-10/2/2012
535Bad news for ARQL's flagship drug, Tiva... l think their burn rate is aboupgo-neil-10/2/2012
534Letter to Shareholders(4/24/12) LETTER TO STOCKHOLDERS We completed a transfArthur Radley-4/25/2012
533Hi Doc! I was madly shooting at shares just after the news came out, but then scaram(o)uche-4/11/2012
532Funny! Yesterday when they announced the deal they mentioned Citi and Leerink asArthur Radley-4/11/2012
531Priced at $7.30. How much is timing, announcing this during one of the bigger otuck-4/11/2012
530Location! Location--in buying real estate! Timing! Timing--in buying biotechs. LArthur Radley-4/10/2012
529NIce of them to wait until the price got back to levels at which they previouslytuck-4/10/2012
528what did you do here rick:-) I wished they waited for 6m... WOBURN, Mass.--(BUSdr.praveen-4/10/2012
527Over the past weekend, GE Healthcare(GE) and (DYAX)made an annnouncement about tArthur Radley-4/3/2012
526onclive.com Interesting article on the c-Met receptor approach for cancer drugsArthur Radley-3/29/2012
525schwab.wallst.com Hummmm! Interesting to see the degree that insiders have beenArthur Radley-1/25/2012
524seekingalpha.comArthur Radley-1/23/2012
523Bad timing on my part! I sold 1/4 of my position week before last in my effort tArthur Radley-1/17/2012
522>>ArQule Announces Tivantinib Meets Primary Endpoint, Significantly Extentuck-1/17/2012
521ARQL just popped on my screen. Any news?lindalib-10/14/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News